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Coxsackievirus B3 (CVB3) is a globally prevalent enterovirus of the Picornaviridae family 
that is frequently associated with viral myocarditis (VM). Neutrophils, as first responders, 
may be key cells in determining viral disease outcomes; however, neutrophils have been 
poorly studied with respect to viral infection. Although neutrophils have been ascribed a 
relevant role in early cardiac inflammation, their precise role in CVB3 infection has not yet 
been evaluated. In this study, we aimed to determine if the interaction between human 
neutrophils and CVB3 could lead to viral replication and/or modulation of neutrophil 
survival and biological functions, and whether neutrophil depletion in a murine model has a 
beneficial or harmful effect on CVB3 infection. Our results show that CVB3 interacted with 
but did not replicate in human neutrophils. Neutrophils recognized CVB3 mainly through 
endosomal TLR-8, and infection triggered NFκB activation. Virus internalization resulted in 
increased cell survival, up-regulation of CD11b, enhanced adhesion to fibrinogen and 
fibronectin, and the secretion of IL-6, IL-1β, TNF-α, and IL-8. Supernatants from infected 
neutrophils exerted chemotactic activity partly mediated by IL-8. The infected neutrophils 
released myeloperoxidase and triggered neutrophil extracellular trap formation in the 
presence of TNF-α. In mice infected with CVB3, viral RNA was detected in neutrophils as 
well as in mononuclear cells. After neutrophil depletion, mice showed reduced VM 
reflected by a reduction in viral titers, cell exudates, and CCL-2 mRNA levels, as well as 
the abrogation of reactive cardiomyocyte hypertrophy. Our results indicate that neutrophils 
have relevant direct and indirect roles in the pathogenesis of CVB3-induced VM.  
 














Abbreviations: CVB3, Coxsackievirus B3; FBS, fetal bovine serum; EeF1A, eukaryotic 
translation elongation factor 1A; ECM, extracellular matrix; HNE, human neutrophil 
elastase; HSV-1, herpes simplex virus 1; IAV, influenza A virus; MOI, multiplicity of 
infection; MPO, myeloperoxidase; NETs, neutrophil extracellular traps; PFU, plaque 
forming units; ROS, reactive oxygen species; TLR, Toll-like receptor; VM, viral myocarditis; 

















CVB3 is a globally prevalent enterovirus of the Picornaviridae family [1] that is frequently 
associated with viral myocarditis (VM) [2]. While acute VM is typically self-limiting in most 
individuals, the development of severe heart muscle injury and/or its persistence, 
sustained by post-viral immune-mediated responses, may lead to dilated cardiomyopathy 
and heart failure in some [3]. The mechanisms underlying the pathogenesis of VM are not 
well-established. Furthermore, therapies for VM are not specific and are directed toward 
supportive care for heart failure [4]. The last stage of inflammatory heart disease, resulting 
in heart failure with transplantation as a frequent therapeutic option, is a major healthcare 
burden worldwide [3].  
The CVB3 murine model has provided significant insights into the pathogenesis of 
VM, as it shares many biological parameters of acute and chronic CVB3-induced diseases 
in humans [2, 5]. A direct role for virus replication, as well as several immune-mediated 
mechanisms, have been involved in CVB3-induced VM [2, 5].  
In humans, neutrophils are the most abundant subset of leukocytes, and they play 
a crucial role in host responses against invading pathogens through an arsenal of toxic 
molecules stored in their intracellular granules, which are released upon activation or 
fused with intracellular compartments containing phagocytosed microbes. In addition, 
neutrophils can produce reactive oxygen species (ROS) through NADPH activation and 
synthesize cytokines with pro-inflammatory activity. Neutrophils are also able to neutralize 
microbes through the release of neutrophil extracellular traps (NETs) [6]. 
In the acute phase of CVB3-induced VM in mice, early cardiac innate cell infiltration 
consisting of macrophages, neutrophils, NK cells and γδ T cells has been demonstrated 
[7]. Although neutrophils have been ascribed to play a relevant role in early cardiac 













Therefore, we aimed to determine if the interaction between human neutrophils and CVB3 
could lead to viral replication and the modulation of neutrophil biological functions. In 
addition, we studied whether depletion of neutrophils would have a beneficial or harmful 
effect on CVB3-induced murine VM.  
2. Materials and methods 
2.1 Isolation of neutrophils  
This study was performed according to institutional guidelines (National Academy of 
Medicine, Buenos Aires, Argentina) and was approved by the Institutional Ethics 
Committee. All subjects provided written informed consent for sample collection and 
subsequent analysis.  
Neutrophils were isolated from peripheral blood drawn from healthy donors. Briefly, blood 
samples were centrifuged on a Ficoll-Hypaque gradient (1.078 g/ml density, GE 
Healthcare, Buckinghamshire, UK) at 400 x g for 30 min at room temperature (RT) 
followed by 6% dextran sedimentation (Sigma, MO, USA) and hypotonic lysis of 
erythrocytes [10]. Cell suspensions that contained ≥99.5% neutrophils as determined by 
flow cytometry were used in all experiments. Neutrophils were suspended in RPMI 1640 
supplemented with 2% fetal bovine serum (FBS) (GIBCO, NY, USA). In selected 
experiments, neutrophils or mononuclear cells (obtained after the Ficoll-Hypaque gradient) 
were stimulated with CL264 or TL8-506 (InvivoGen, CA, USA) (TLR-7 and TLR-8 agonists, 
respectively) or treated with bafilomycin A1 (inhibitor of the vacuolar type H+ATPase) 
(InvivoGen). 
 
2.2 Cells and viral stocks 
Vero-76 cells (American Type Culture Collection, VA, USA) were maintained as 













(H3) strain [11] was propagated in Vero cells, and infectivity titration assays were 




2.3 Cell infection 
Neutrophils (1x105) or a monolayer of Vero cells (1x105) (as a positive control) were 
inoculated with CVB3 at a multiplicity of infection (MOI) of 0.1, 1 and 10 for 3 h at 37ºC. 
After three exhaustive washes to ensure viral removal, neutrophils and Vero cells were 
suspended in 200 µl of RPMI 1640 with 2% FBS. Mock infection (as a negative control) 
was performed by replacing the same volume of virus inoculum with uninfected Vero cell 
supernatant. 
 
2.4 Viral detection by immunofluorescence and flow cytometry 
Neutrophils (1x105) or a monolayer of Vero cells (1x105) were incubated with CVB3 (MOI 
of 1) for 3 h, washed and cultured for 1 and 24 h post-infection (hpi) in RPMI medium 
supplemented with 2% FBS. At any given time point, cells were fixed with 1% 
paraformaldehyde (PFA), centrifuged and permeabilized with 0.1% Triton X-100. After 
blocking with 10% FBS, the cells were incubated for 1 h with the primary antibody (Ab) 
against the enterovirus VP1 capsid protein (Dako, Glostrup, Denmark), followed by an 
Alexa Fluor 488-conjugated secondary Ab (Life Technologies, NY, USA). Cells were 
mounted on slides and analyzed by confocal microscopy (Olympus FV-1000, Tokyo, 
Japan). Surface and intracellular detection of CVB3 were determined by flow cytometry in 
non-permeabilized or permeabilized neutrophils, respectively. After infection, the cells 
were centrifuged and treated for 30 min with Fix and Perm (BD Biosciences, CA, USA) 













the cells were stained with an Alexa Fluor 488-conjugated secondary Ab for further 15 min 
and finally suspended in Isoflow (BD) and analyzed using a FACSCalibur flow cytometer 




2.5 RT-PCR and qPCR  
The presence of viral RNA, as well as TLR-7, TLR-8, CCL-2 and Eef1A mRNA was 
analyzed by RT-PCR/qPCR using specific primers (5’>3’): CVB3 fwd: 
CGGCCCCTGAATGCGGCTAA, rev: GAAACA CGGACACCCAAAGTA; TLR-7 fwd: 
CAAGAAAGTTGATGCTATTGGGC, rev: TTCGTGGTGTTCGTGGGAAT; TLR-8 fwd: 
AGAACA-ACAGAAACATGGAAAACAT, rev: CCGTTTGGGGAACTTCCTGT; CCL-2 fwd: 
TGCCCTAAGGTCTTCAGCAC, rev: AAGGCATCACAGTCCGAGTC; Eef1A fwd: 
TCGGGCAAGTCCACCACTAC, rev: CCAAGACCCAGGCATACTTGA. Total RNA was 
isolated from cell or tissue pellets using TriReagent (Genbiotech, BsAs, Argentina). Prior 
to cDNA synthesis, DNase treatment was performed with an RNase-free DNase Kit 
(Qiagen, CA, USA). The cDNA was synthesized from 1 µg of total RNA using 15 mM of 
random hexamers (Biodynamics, BsAs, Argentina) and MMLV reverse transcriptase 
(Promega, BsAs, Argentina). The obtained cDNA was used as a template for PCR, with 
the experiments performed in triplicate. For CCL-2, the qPCR procedure was used as 
previously described [13]. 
 
2.6 Detection of neutrophil supernatant infectivity by viral plaque assays 
To determine whether neutrophils were infected, the cells (1x10
5
) were incubated with 
CVB3 at an MOI of 1 for 3 h. Vero cells were then incubated with supernatants or pellets 













formation of plaque forming units (PFU) was revealed by methanol and crystal violet 




2.7 Expression of CD11b  
To evaluate CD11b expression, neutrophils (1x105) were infected with CVB3 and then at 
different times pi, the cells were fixed and stained with PE-conjugated CD11b or an 
irrelevant IgG1 (Biolegend, CA, USA). The cells were then analyzed by flow cytometry. 
 
2.8 Neutrophil adhesion assay 
A 96-well plate was coated with fibrinogen (100 µg/ml) or fibronectin (10 µg/ml) and left 
overnight at 4°C. The plate was then washed and blocked with 2% heat-inactivated BSA, 
and aliquots of neutrophils (1x105) were added to each well, uninfected or infected with 
CVB3, and then incubated at 37ºC for 3 h. After washing, a solution of 5 mM p-nitrophenyl 
phosphate in 0.1 M citrate buffer containing 0.1% Triton X-100, pH 5.4 was added and 
incubated for 1 h at 37ºC. The reaction was stopped by adding 2 N NaOH, and the 
absorbance at 405 nm was measured with a microplate reader (Dynatech MR 5000; 
Dynatech Laboratories). 
 
2.9 Production of pro-inflammatory cytokines and IL-8 
After neutrophil infection with CVB3 for 18 h, the cells were centrifuged at 600 x g for 10 
min and the production of IL-6, IL-1β, TNF-α and IL-8 was determined in the supernatants 















2.10 Neutrophil chemotaxis assay 
Neutrophils (1x105) were suspended in RPMI with 2% FBS, and chemotaxis was 
quantified using a modification of the Boyden chamber technique. Cell suspension was 
placed in the upper wells of an 18-well micro chemotaxis chamber (Neuro Probe, MD, 
USA), separated by a polyvinylpyrrolidone (PVP)-free polycarbonate filter (3 μm pore size; 
Poretics Products, CA, USA). The lower wells contained the supernatant from infected or 
uninfected neutrophils. The chamber was incubated for 30 min at 37°C in a 5% CO2 
humidified atmosphere. Following incubation, the chamber was disassembled and the 
membrane removed, fixed and stained with Staining 15 (Biopur Diagnostics, Argentina). 
The number of neutrophils that migrated through the filter was counted in five random 
high-power fields at a magnification of 400x per condition (each condition in triplicate) 
employing an optical microscope. Results are expressed as the number of migrated 
neutrophils per field. In selected experiments, supernatants from infected neutrophils were 
incubated with a neutralizing Ab against IL-8 or an IgG control. 
 
2.11 Determination of neutrophil apoptosis and viability  
Neutrophils were cultured in RPMI with 2% FBS in the presence or absence of CVB3. At 
24 hpi, the cells were analyzed for changes in nuclear morphology and viability by labelling 
with a mixture of acridine orange and ethidium bromide (100 µg/ml) to determine the 
percentage of cells that had undergone apoptosis [14]. Apoptosis was also determined by 
analyzing the percentage of hypodiploid cells. After infection, the cells were fixed with ice-
cold 70% ethanol overnight, washed three times, and then suspended in a solution 
containing 1 mg/ml RNase and 2 μg/ml propidium iodide (PI) (Sigma). After 15 min, the 















Neutrophils were incubated for 3 h with CVB3 and then solubilized in loading buffer (62.5 
mM of Tris-HCl at pH 6.8, 25% glycerol, 2% SDS, 0.01% bromophenol blue and 5% 2-
mercaptoethanol). Equal amounts of sample proteins were electrophoresed on a 10% 
SDS-PAGE gel and electrotransferred to nitrocellulose membranes. After blocking, the 
membranes were incubated with primary Abs anti-IκBα and anti-β-actin (BD Biosciences), 
followed by incubation with HRP-conjugated secondary Abs. Protein bands were 
visualized by enhanced chemiluminescence (ECL Plus; GE Healthcare, Buckinghamshire, 
UK). 
 
2.13 Myeloperoxidase activity  
Myeloperoxidase (MPO) activity was measured in supernatants from neutrophils 
uninfected or infected with CVB3 for 3 h at 37°C in RPMI 1640 medium supplemented with 
2% FBS. MPO was evaluated by adding the high sensitivity substrate TMB (Thermo Fisher 
Scientific, MA, USA), and absorbance was read at 450 nm after stopping the reaction with 
2 N sulfuric acid. The calibration curve was constructed using purified MPO of a known 
concentration. 
 
2.14 Generation of reactive oxygen species  
To determine reactive oxygen species (ROS) production, uninfected or infected 
neutrophils were incubated with dihydrorhodamine (DHR, 5 μM) for 30 min at 37°C and 
analyzed by flow cytometry. 
 
2.15 Formation of neutrophil extracellular traps (NETs) and DNA release 
quantification 
Neutrophils (1x105) were seeded in 24-well flat-bottom-plates with coverslips, infected with 













with CO2 (5%) for 180 min. The cells were then fixed with PFA (1%), blocked with 10% 
heat-inactivated FBS and stained with rabbit anti-human elastase (HNE) or the 
corresponding IgG controls (Calbiochem-Merck Millipore, Darmstadt, Germany). For HNE 
identification, cells were incubated with an Alexa Fluor 488-labeled goat anti-rabbit 
secondary Ab and the DNA was stained with PI (20 µg/ml). Mounted specimens were 
analyzed by confocal fluorescence microscopy. For quantification purposes, neutrophils 
were incubated with CVB3 or TNF-α (10 ng/ml) plus CVB3 (MOI=1) in the absence or 
presence of bafilomycin A1 (50 nM), Then, DNA released from neutrophils during NETosis 
was digested with micrococcal nuclease (500 mU/ml, Roche Diagnostics, Mannheim, 
Germany) for 15 min. EDTA (5 mM) was added to stop the nuclease activity, and the 
supernatants were collected and centrifuged, after which the DNA was measured using 
SYBR Gold in a fluorometer (BioTek Instruments, VT, USA). TL8 506 was used as a TLR-
8 agonist. The calibration standard curve was constructed using thymus DNA of a known 
concentration [15]. 
 
2.16 Neutrophil depletion and mouse infection  
All experiments were performed in accordance with the American Physiological Society’s 
Guiding Principles for the Care and Use of Animals in Research (American Physiological 
Society) and federal law on the use of experimental animals (Animal Welfare Act) and 
were approved by the Institutional Animal Care and Use Committee.  
Male C57BL/6 mice, 6 to 7 weeks old (Charles River Laboratories, Wilmington, MA), were 
housed in a level 2 containment facility. Food and water were available ad libitum. The 
conditions of the mice were monitored daily. Neutrophil depletion was induced by an 
intraperitoneal (i.p.) inoculation with 100 µl of PBS (endotoxin-free) containing 100 µg of 
anti-Ly6G (1A8clone, BioXCell, NH, ref BE0075-1) every 24 h. Control mice were 













conditions. The first inoculation was performed one day before infection and then at every 
24 h. Mice were i.p. inoculated with 2x105 PFU of virus in 200 µl of PBS. To determine 
viremia, on 2 dpi, the mice were anesthetized with an i.p. injection of 2,2,2-tribromoethanol 
in tert-amyl alcohol (Avertin; Aldrich Chemical Co., WI, USA) and blood was drawn into 
plastic tubes containing 3.8% sodium citrate. The plasma sample was obtained by 
centrifugation at 600 x g for 10 min. On day 7 pi, all mice were anesthetized with Avertin, 
and blood samples were obtained to determine hematological counts using a veterinary 
hematological analyzer (Abacus Jr Vet, Vienna, Austria). Afterward, the mice were 
euthanized by cervical dislocation, and the hearts were removed aseptically and split in 
half along the long axis. One part was homogenized using a Bio-Gen PRO200 
homogenizer, as recommended by the manufacturer, in 1 ml of sterile PBS. After 
clarification, the homogenates were titrated for virus infectivity determination. The other 
half was fixed in 4% PFA, processed for routine histology and used to determine a 
myocarditis score [13]. 
 
2.17 Immunohistochemistry 
Cell exudates were characterized as previously described with minor modifications [13, 16] 
using 8-m paraffin-embedded sections from the CVB3, Iso + CVB3 and 1A8 + CVB3 
groups since there were no infiltrates in the control and 1A8 groups. In contrast, for p53 
expression studies, all groups were included. Briefly, after rehydration, the tissue Pro-Bond 
Plus sections were heated three times for 5 min in 10 mM citrate buffer in a microwave 
oven. The sections were then cooled and immersed in 3% H2O2 for 15 min to inhibit 
endogenous peroxidase activity. To block non-specific antigen sites, sections were 
incubated with PBS + 5% normal goat serum for 20 min at RT. Sections were then 
incubated with the respective primary antibodies: anti-CD4, anti-CD8, anti-CD45R and 













anti-macrophage (MAC-2, clone M3/38) antibodies. The primary antisera were applied to 
sections overnight at 4°C, washed for 15 min, and then incubated with the secondary Ab  
(goat anti-rabbit/mice immunoglobulin) conjugated to peroxide-labeled dextran polymer 
(DAKO EnVision) or anti-rat peroxidase for 20 min at RT and again washed with PBS. 
Diaminobenzidine/hydrogen peroxidase substrate (DAB) was added until the appropriate 
intensity was obtained and slides were then rinsed with distilled water to stop the staining 
reaction. Immunostained sections were slightly counterstained with hematoxylin and 
dehydrated, mounted and observed under a Nikon E200 photomicroscope. As a control for 
the effectiveness of the primary Ab, sections were equally treated but without primary Ab 
incubation. Quantification of the cells in infiltrates was performed by counting 
immunostained cells, using a 40x objective with a grid area of 0.04 mm 2. Serial sections 
were made from areas with inflammation and/or necrosis in order to analyze the same 
area with different antibodies. Three animals were examined for each condition. Ten to 
twenty grids from each section were evaluated. The total number of infiltrating cells 
counted was generally about 100-200. 
 
2.18 Analysis of cardiomyocyte size 
Samples used for analysis were taken from formalin-fixed paraffin embedded hearts from 
all groups of mice studied. After rehydration, samples were stained with HBSS containing 
Alexa Fluor 594-conjugated wheat germ agglutinin (WGA, 5 μg/ml, Invitrogen, Argentina) 
to delineate the cell membrane [17]. Samples were washed and mounted in a solution 
containing DAPI for nuclear staining and photographed in a Nikon E200 equipped with a 
fluorescence system. For the analysis of cardiomyocyte size, Image J software (NIH, USA) 
was used following the instructions provided with the software and whole-slide images 













membranes and visible cell nuclei at mid-wall depth with an apparent transversal 




2.19 Isolation of neutrophils from murine white blood cells by fluorescence 
activated cell sorting (FACS). 
Briefly, infected C57BL/6 mice were anesthetized with Avertin and bled at 2 days post-
infection. Whole blood samples were centrifuged at 600 x g for 15 min at RT and the 
platelet-rich plasma was discarded. After the lysis of murine red blood cells, leukocytes 
were blocked with physiological saline solution + 5% FBS and then were stained with anti-
VP1 and Ly6G Abs, followed by conjugated secondary Abs. Cells were then resuspended 
in Isoflow (BD) and analyzed by flow cytometry by acquiring 10,000 events in the 
neutrophil gate. To sort the population of pure neutrophils (Ly6G+ cells), the same 
procedure described above was followed, but cells were only stained with Ly6G Ab. 
Sorting was performed with a FACS Aria fusion apparatus. A post-sort analysis was 
performed to determine the purity of neutrophils, which was 98.2±0.4%. 
 
2.20 Statistical analysis 
The results are expressed as the mean and the SEM. Each n represents a different donor. 
One-way analysis of variance (ANOVA), followed by the Bonferroni test, was employed to 
determine the significance of differences between groups. A P value lower than 0.05 was 
















3.1 CVB3 is internalized by neutrophils 
We initially explored the CVB3-neutrophil interaction by incubating human neutrophils with 
CVB3 at several time points, followed by immunofluorescent detection of viral antigen. 
Extensive washing was performed prior to virus detection to ensure removal of the 
exogenously inoculated virus, and infected Vero cells were used as positive controls. The 
CVB3 VP1 capsid protein was detected by immunofluorescence in some neutrophils at 1 
and 24 hpi, as well as in the Vero cells (1 hpi) used as positive controls (Figure 1A). To 
address whether the virus was located in the membrane or in the intracellular 
compartment, flow cytometry experiments were performed in both permeabilized and non-
permeabilized cells. In non-permeabilized infected neutrophils, the percentage of cells 
containing surface-associated viral antigen was 4%±1, while this value increased to 
11±2% (n=3) in permeabilized cells, indicating that CVB3 was mostly internalized by 
neutrophils (Figure 1B).  
 
3.2 CVB3 does not replicate in neutrophils 
Given that CVB3 was detected in human neutrophils, we wondered whether the virus was 
able to replicate in these cells. For that purpose, the infectivity titers in pellets or 
supernatants were determined over time. Although infectious CVB3 was detected in both 
neutrophil supernatants and pellets, the viral titer levels diminished with time (Figure 2A). 
In contrast, and as expected, the Vero-infected supernatants and pellets showed a 
significant increase in infectivity titer levels from 1 to 24 hpi (Figure 2A), with almost 100% 
of the monolayer showing a cytopathic effect at 24 hpi. 
Considering the short half-life of neutrophils and that the lack of increasing titers may be 
due to increasing cell death, we explored if the negative-sense single stranded RNA, 
theoretically present only in cells with ongoing viral genome replication, could be detected. 













in the viral stock (Supplementary Figure 1). To further determine if the virus replicated in 
neutrophils, the levels of viral RNA versus time were analyzed by semi-quantitative RT-
PCR. The results show that the viral RNA in neutrophils clearly diminished over time 
(Figure 2B). Together, these data strongly suggest that CVB3, although incorporated into 
the neutrophil cytoplasm, does not replicate.  
 
3.3 CVB3 increases neutrophil binding to ECM and chemokine release  
As it has been demonstrated that some viruses induce several neutrophil activation 
responses, including CD11b expression [18], the main mediator of neutrophil-endothelial 
cell interaction, we next explored CD11b expression on CVB3-infected neutrophils. Figure 
3A shows that CVB3 infection resulted in increased CD11b expression levels after 1 hpi, in 
an MOI-dependent manner. Because CD11b is a receptor with several ligands, including 
many proteins associated with the extracellular matrix (ECM) [19, 20], the eventual 
functionality of its increased expression was analyzed by studying neutrophil adhesion to 
plates coated with fibrinogen or fibronectin at 3 hpi (followed by phosphatase acid activity 
quantification). While non-infected neutrophils showed little adhesion to either fibrinogen or 
fibronectin, neutrophils infected with CVB3 had an enhanced ability to bind to both ECM 
proteins (Figure 3B and Supplementary Figure 2A). Because IL-8 is a major chemokine 
known to facilitate neutrophil extravasation [21], in the next experiments, we studied if 
CVB3 infection induced IL-8 secretion. Figure 3C shows that the levels of IL-8 in the 
supernatants from infected neutrophils were significantly higher than those observed in 
non-infected or mock samples. As human circulating neutrophils enter the site of infection 
by mainly migrating along a gradient of IL-8, and to find a functional correlate of this IL-8 
increase, the chemoattractant capacity of the supernatants derived from infected and non-
infected cells was evaluated using a modified Boyden chamber assay. While supernatants 













compared with control samples, supernatants derived from CVB3-infected neutrophils 
showed a significantly higher ability to attract neutrophils than those from mock and non-
infected cells (Figure 3D and Supplementary Figure 2B). Preincubation of supernatants 
from CVB3-infected neutrophils with a neutralizing Ab against IL-8 significantly diminished 
chemotaxis, suggesting a relevant role of this chemokine in the chemoattractant activity of 
neutrophils (Figure 3D).  
 
3.4 CVB3 infection increases neutrophil survival 
Because exposure to bacteria is known to prolong neutrophil half-life through the inhibition 
of apoptosis [22], we explored whether CVB3 had a similar effect. At 24 hpi, analysis of the 
nuclear morphology showed that CVB3 infection induced a reduction in the number of 
apoptotic cells (Figure 4A). In addition, flow cytometric studies also showed that the 
number of hypodiploid cells was significantly lower in infected cells compared with mock 
and control neutrophils (Figure 4B). To determine whether the increase in cell survival was 
associated with the secretion of cytokines, we evaluated the levels of several cytokines 
known to modulate the neutrophil fate. CVB3 infection induced a significant increase in the 
levels of IL-1β, TNF-α and IL-6 (Figure 4C). Moreover, in order to determine whether 
infectious virus was required to induce cytokine release, neutrophils were exposed to UV-
inactivated CVB3. We found no differences in the release of IL-6 induced by infective or 
non-infective CVB3 (Figure 4C).  
Activation of the transcription factor NFκB is a major pathway involved in cytokine release 
upon neutrophil activation [23]. Accordingly, we observed that neutrophil infection with 
CVB3 resulted in degradation of the NFκB inhibitor IκBα (Figure 4D), suggesting that the 
NFκB pathway was activated upon virus infection.  
 













The neutrophil effector responses triggered by CVB3 infection indicated that pathogen-
recognition receptors sensed CVB3 in these cells. Because the antiviral response is 
mediated by endosomal TLRs [24], we first analyzed the effect of bafilomycin A1, an 
inhibitor of the vacuolar type H+ATPase, and found that CVB3-induced IL-6 release was 
suppressed in neutrophils pretreated with bafilomycin A1 (Figure 5A). Among the different 
endosomal TLRs, TLR-3, TLR-7 and TLR-8, but not TLR-9 (which recognizes DNA rich in 
CpG motifs), might be capable of sensing CVB3 [24]. While TLR-3 is not expressed in 
neutrophils [25], the expression of TLR-7 and TLR-8 is still controversial [25-29]. Next, we 
analyzed the expression of both TLRs and the effect of neutrophil stimulation with CL264 
and TL8-506, specific agonists of TLR-7 and TLR-8, respectively. While TLR-8 mRNA was 
highly expressed in all neutrophil samples, TLR-7 was barely expressed or not detected 
(Figure 5B). Accordingly, IL-6 was significantly increased upon the treatment of neutrophils 
with TL8-506 but not with CL264 (Figure 5C). The functionality of TLR-7 agonist was 
verified by stimulating peripheral blood mononuclear cells, which released IL-6 in a 
concentration-dependent manner upon activation with CL264 (Figure 5D). Together, these 
data indicate that CVB3 infection in neutrophils is mainly detected by endosomal TLR-8. 
 
3.6 CVB3 infection increases neutrophil strategies of pathogen elimination  
Pathogen elimination is a major effector response of neutrophils during infection. 
Therefore, we also studied whether CVB3 infection modulates three different mechanisms: 
granular content release, measured as MPO activity in the supernatants, the generation of 
ROS and NET formation. Although CVB3 infection increased MPO activity and the 
synthesis of ROS, the latter was not statistically significant (Figure 6A-B). We also 
observed that CVB3 per se only enhanced NETosis in a discrete manner. However, CVB3 
infection markedly increased NET release in neutrophils that were previously primed by 













al. have shown that HIV induces NETosis through TLR8 activation [30]. In agreement, we 
found that when neutrophils were incubated with CVB3 or TNF-α (10 ng/ml) in the 
presence of bafilomycin A1 (50 nM), there was a significant decrease in NET formation. 
Moreover, stimulation of neutrophils with TL8 506, a TLR-8 agonist, triggered NETosis; 
this effect was significantly increased when neutrophils were previously incubated with 
TNF-α (Figure 6D).  
 
3.7 Role of neutrophils in CVB3-induced myocarditis  
To determine whether virus internalization by neutrophils occurs in vivo, mice were 
infected with CVB3 and, 2 days post-infection (dpi), total leukocytes were double labeled 
with anti-Ly6G (neutrophils) and anti-VP1 (viral antigen). Figure 7A and B showed that 
there were no viral infected cells in the Ly6G population. Moreover, there were no viral 
infected cells in the whole leukocyte population (data not shown). On the other hand, 
infected Vero cells were clearly positive for VP1, indicating the functionality of the assay 
(Figure 7B). Considering that flow cytometry was not sensitive enough to detect the 
presence of virus, we then performed RT-PCR and found that whole blood leukocytes 
contained viral RNA. Moreover, sorting of infected neutrophils demonstrated that the virus 
was in the Ly6G+ neutrophils as well as in the Ly6G- mononuclear cells (Figure 7C).  
To further clarify the role of neutrophils in acute VM, survival, viral titers and cardiac 
pathology were studied in infected mice without and with depletion of neutrophils by anti-
Ly6G (clone 1A8) treatment. The depletion protocol achieved and maintained a depletion 
of blood neutrophils in a range from 96 to 99%, with minor no statistically significant effects 
on the percentages of lymphocytes and monocytes (Figure 8A). All mice showed a 100% 
survival rate. At 2 dpi, viremia was slightly reduced in the 1A8+CVB3 mice compared with 
the CVB3 group (Figure 8B). Similarly, cardiac viral burden at 7 dpi was also mild but 













The histopathological analysis showed an absence of abnormalities in control mice (Figure 
9A). In contrast, CVB3-infected and control isotype-infected mice showed typical multifocal 
myocarditis that was significantly reduced in 1A8+CVB3 mice, scoring 1.75±0.36 and 
0.34±0.05, respectively (Figure 9A). Moreover, the mRNA levels of the inflammatory 
marker CCL-2 supported the histology data since CVB3-infected mice showed a significant 
increase in CCL-2 levels that were reduced in depleted animals (Figure 9B).  
To characterize the inflammatory cell infiltrates, immunohistochemical studies using cell-
specific antibodies for neutrophils, macrophages, and T and B lymphocytes were 
performed on cardiac samples from mice at 1 week p.i. (Figure 9C). Cell infiltrates, 
composed mainly of macrophages and T lymphocytes, were frequently associated with 
necrotic fibers. As expected, after depletion, neutrophils could not be detected in the 
infiltrates and the total number of inflammatory of cells was significantly reduced. 
Neutrophil depletion did not lead to major changes in the infiltrates between groups (Table 
I). 
Using WGA staining and digital image analysis, we characterized cell size in all groups of 
studied animals. The results showed similar values for the control and 1A8 animal groups. 
Both the CVB3 and Iso+CVB3 groups showed a significant increase in cell area (Figure 
9D) that was reduced in the 1A8+CVB3 group (Figure 9D), suggesting that CVB3-induced 
myocarditis produced reactive cardiomyocyte hypertrophy that was partially abrogated in 
neutrophil-depleted mice.  
To determine whether CVB3 infection induced cardiomyocyte apoptosis, we performed 
p53 staining [31, 32]. As shown in Supplementary Figure 3, there were no significant 
numbers of p53+ cells in the hearts of infected animals, suggesting that cardiomyocyte 
apoptosis was not a major event in CVB3-induced murine myocarditis. Taken together, our 
results indicate that neutrophil depletion leads to a decreased viral cardiac burden, 















Neutrophils act as the first line of defense against harmful microorganisms. Many studies 
have investigated the role of neutrophils in the pathogenesis of bacterial and fungal 
infections [33]; however, there is much less information regarding the role of neutrophils in 
viral pathogenesis, particularly in viral myocarditis. In this study, we demonstrate that 
CVB3 is internalized by human neutrophils, and that, although the virus does not replicate, 
it triggers several activation effector responses and prolongs the life span of neutrophils.  
After exposure to CVB3, VP1 was detected on the neutrophil surface and inside the cell. It 
has been reported that neutrophils do not express the CVB receptor CAR [34]; however, 
the fact that lymphocytes express it in very small amounts but are efficiently infected [35] 
and that platelets interact with CVB in a CAR-independent way [36] suggests the existence 
of alternative mechanisms for viral entry, at least for neutrophil cells. 
 Although the general concept is that neutrophils are not a target for viruses, the recent 
observation that influenza A targets neutrophils and is able to replicate in these cells [37] 
calls for a reconsideration of the role of these cells in viral infections. In this sense, 
neutrophils were shown to contribute to both viral clearance [30, 38] as well as viral 
dissemination [39, 40]. Although we found infectious viral particles in the supernatants and 
pellets of CVB3-infected neutrophils, the fact that these levels did not increase over time 
may be a result of a lack of viral replication or increased cell death due to the short half-life 
of neutrophils. As we found that CVB3 infection prolonged neutrophil half-life, the fact that 
viral RNA levels were significantly reduced after 48 hpi strongly suggests that CVB3 did 
not replicate in these cells. 
Infection of neutrophils with CVB3 resulted in the up-regulation of CD11b, which was 
associated with an augmented adhesion to the extracellular matrix proteins, fibrinogen and 













episodes involves a complex series of adhesive interactions and signaling events. The 
adhesive interactions between leukocyte CD11b/CD18 and fucosylated glycoproteins 
expressed at basal levels, followed by binding to desmosome-associated JAM-C, are key 
elements of the transmigration response [41]. Thus, it might be conceivable that the up-
regulation of CD11b represents a CVB3 strategy to facilitate neutrophil migration towards 
target organs and enhance virus dissemination.  
Bacterial activated neutrophils can release granular components and chemokines, which 
recruit more neutrophils along with other immunocompetent cells to the site of infection 
[33]. Our findings showing that CVB3-infected neutrophils secreted IL-8, and that the 
supernatants of these infected cells promoted neutrophil migration, suggest that 
chemokine production by activated neutrophils is not specific to bacterial infection but 
instead represents a phenomenon that might also be elicited by viral infections . Of note, 
the chemotactic activity of supernatants from CVB3-infected cells was significantly 
decreased in the presence of an IL-8 blocking Ab, suggesting that IL-8 is involved in the 
chemotactic response of CVB3-infected neutrophils. Our findings also imply that CVB3-
infected cells may be capable of directing their own recruitment to sites of inflammation 
and infection, thus boosting acute inflammatory responses against infection. 
CVB3 infection prolonged the survival of neutrophils, associated with a marked release of 
IL-1β, TNF-α and IL-6, pro-inflammatory cytokines that also promote neutrophil survival 
[22, 42]. Interestingly, the secretion of similar cytokines upon CVB3 infection was 
demonstrated in early studies on human monocytes. However, in that study, the effect of 
cytokines on monocyte survival was not addressed [43]. The main molecular pathway 
involved in the release of pro-inflammatory cytokines and neutrophil survival under 
inflammatory conditions is NFκB [44]. Accordingly, we observed that neutrophil infection 













suggesting that this signaling pathway could represent a potential target for decreasing 
inflammation during viral infections. 
ssRNA viruses can be sensed by cytoplasmic TLR-7 and TLR-8 [45], which initiate the 
inflammatory response upon activation of the downstream signal NFκB. In this context, it 
has been reported that the CVB3-induced inflammatory response is mediated through the 
up-regulation and activation of cardiac TLR-8 and, to a lesser extent, TLR-7 [46]. Our data 
showing that inhibition of the vacuolar type ATPase impeded cytokine release, that TLR-8 
but not TLR-7 is highly expressed in neutrophils and that an agonist of TLR-8 but not of 
TLR-7 mimicked the IL-6 release induced by CVB3, strongly indicate that CVB3 in 
neutrophils is mainly recognized by TLR-8.  
Neutrophils combat invading microorganisms by activating several strategies, including 
ROS generation and the release of antimicrobial molecules such as MPO and NETs [47]. 
Our data show that CVB3 infection triggered the secretion of MPO and NET formation. As 
mentioned above, viral RNA was not detected after 48 hpi. Because ROS and MPO can 
have direct virucidal effects, it can be speculated that these molecules could have been 
involved in viral degradation. 
While NETs were first described as a mechanism against bacteria and fungi, several 
studies have recently shown that some viruses, including influenza A [48], HIV-1 [30] and 
hantavirus [49], trigger NET formation. Although we observed minor NET induction upon 
neutrophil infection with CVB3, priming the cells with the pro-inflammatory cytokine TNF-α 
resulted in a marked increase in extracellular DNA release. Considering that TNF-α is one 
of the major cytokines released from CVB3-infected monocytes [43], these findings 
suggest, that together with monocytes, the formation of DNA traps by neutrophils might 
contribute to virus elimination and/or tissue damage. In agreement with a previous study 













TNF-α was inhibited by bafilomycin and mimicked by a TLR8 agonist. Together, these data 
indicate that TLR8 is responsible for NET formation induced upon RNA virus recognition. 
Although neutrophils are the first and most predominant immune cell population recruited 
to an affected site after tissue injury, the contribution of neutrophils to antiviral defense is 
much less appreciated compared to their role in bacterial or fungal infection. Neutrophils 
may exert beneficial as well as harmful effects during viral infections [50]. The beneficial 
role of neutrophils has been demonstrated in experimental models of influenza A virus 
(IAV) [51, 52] and herpes simplex virus 1 (HSV-1). However, it has also been shown that 
the excess activation of neutrophils leads to detrimental effects on the host due to the 
release of pro-inflammatory mediators and toxic substances that can induce pathologic 
features [50]. In fact, neutrophil-mediated detrimental effects, including pneumonia and 
respiratory distress syndrome, have been observed in IAV infections [53], stromal keratitis 
lesions induced by HSV [54] or liver damage in mice infected with murine Cytomegalovirus 
[55]. Regarding CVB3-induced VM, our results show that although all infected groups 
presented viral replication and myocardial necrosis, these parameters were significantly 
reduced in neutrophil-depleted mice. The composition of the cell infiltrate was similar to 
those described in other studies, with the prevalence of mononuclear cells and relatively 
fewer neutrophils [56-59]. Although our study has the limitation of not having used 
echocardiography or another functional assessment, moderate reactive hypertrophy in 
CVB3-infected mice was found by performing a cardiomyocyte analysis, as described by 
other groups [60, 61]. The detection of p53 protein expression, used to detect apoptosis 
[32], showed scattered p53-positive cardiomyocytes and cell exudate cells in the infected 
groups with no differences among them. Therefore, and in contrast to human VM [31], 
apoptosis does not represent a major cause of cell death in the murine model of CVB3-
induced VM, in agreement with other studies [62, 63]. The reduced myocardial necrosis 













This reduction in cardiac viral burden was somewhat unexpected and may indicate that 
neutrophils directly or indirectly participate in viral dissemination. However, it should be 
noted that, although statistically significant, the decrease was minor, and therefore the 
biological significance of these data is not clear. On the other hand, the reduced 
inflammatory response and cardiac damage observed by histological analysis and 
supported by CCL-2 mRNA levels suggest that neutrophils contribute to VM development. 
In this sense, our in vitro data suggest that neutrophils can affect cardiac cells by releasing 
toxic pro-inflammatory mediators such as neutrophil-derived IL-1β, TNF-α, IIL-6 and IL-12 
[59] that favor cell exudate accumulation, together with ROS and NETs, which can induce 
tissue damage.  
In conclusion, our study demonstrates that CVB3 interacts with and activates neutrophils, 
endowing these innate immune cells with a relevant role in the pathogenesis of viral 
myocarditis. A better understanding of the role of neutrophils with respect to viral infections 
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Figure 1. Coxsackievirus B3 (CVB3) interacts with neutrophils. Human neutrophils 
and Vero cells were uninfected or infected with CVB3, and the presence of viral particles 
was detected at 1 or 24 h hpi. Monolayer of infected Vero cells shows 100% cytopathology 
by 24 hpi. A) The expression of the enterovirus protein VP1 was determined by 
immunofluorescence and analyzed by confocal microscopy. Original magnification 60x 
(scale bar: 20 μm). B) Surface (non-permeabilized cells) and intracellular VP1 expression 
(permeabilized cells) were determined by flow cytometry. The images are representative of 
three independent experiments. 
Figure 2. CVB3 does not replicate in neutrophils. A) Vero cells and neutrophils were 
infected with CVB3 (MOI 1), and plaque-forming units (PFU) in the supernatants (Sup) and 
pellets were quantified at different times pi by the infectivity titration assay in Vero cells. B) 
CVB3 mRNA (RNA) was detected by RT-PCR. The results are the mean±SEM of three 
independent experiments (****P<0.0001 vs 1 hpi).  
 Figure 3. CVB3 interaction with neutrophils triggers adhesion and migration 
responses. All responses were determined in non-infected (control and mock) and 
infected neutrophils A) CD11b expression was determined by flow cytometry, and the 
results were expressed as the mean fluorescence intensity (MFI). B) Neutrophils were 
seeded on fibrinogen or fibronectin coated-wells, and 3 h later, adhesion was evaluated by 
phosphatase acid activity quantification. AU: arbitrary units. C) IL-8 levels were determined 
in the supernatants after 18 h of infection. D) Neutrophil chemotaxis was quantified using 
the Boyden chamber technique. The cells were placed in the upper wells, and the 
supernatant from infected (incubated with IgG or anti-IL-8) or non-infected neutrophils was 
added to the lower wells. The number of neutrophils that migrated through the filter was 
counted in the five random higher-power fields (400x). The results are the mean±SEM of 
four to five independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 













Figure 4. Neutrophil infection with CVB3 inhibits apoptosis, induces cytokine 
release and activates transcription factor NFκB. All responses were determined in non-
infected (control and mock) and infected neutrophils. The percentage of apoptotic cells 
was evaluated by A) monitoring nuclear morphology changes and viability by labelling cells 
with a mixture of acridine orange and ethidium bromide (100 µg/ml) and B) detection of 
hypodiploid cells by flow cytometry. C) The release of IL-1β, TNF-α and IL-6 was 
determined in the supernatants 18 h after virus infection by ELISA. IL-6 levels were also 
analyzed in cells infected with UV-inactivated virus (i-CVB3). D) Activation of NFκB was 
evaluated by degradation of its inhibitor IκBα by Western blotting. The results are the 
mean±SEM of three to five independent experiments (*P < 0.05 and **P < 0.01 vs. control, 
#P < 0.05 and ##P < 0.01).  
Figure 5. Neutrophils sense viral infection through TLR-8. A) IL-6 secretion was 
measured by ELISA in the supernatants of neutrophils infected with CVB3 in the absence 
or presence of bafilomycin A1 (50 nM). B), an inhibitor of vacuolar type H+ATPase. 
Neutrophil mRNAs encoding TLR-7 and TLR-8 were detected by RT-PCR in cells from 
three independent donors. Peripheral blood mononuclear cells (PBMC) were used as the 
positive control for TLR-7 and TLR-8. C) IL-6 release was measured in the supernatants of 
neutrophils that were stimulated for 18 h with different concentrations of TL8-506 and 
CL264, which are TLR-8 and TLR-7 agonists, respectively. D) IL-6 levels detected in the 
supernatants of peripheral blood mononuclear cells that were stimulated with different 
concentrations of CL264. The results are the mean±SEM of three to six independent 
experiments (**P 0.01 < vs. Mock, *P < 0.05, and ***P 0.001 < vs. None and ##P < 0.01). 
Figure 6. Neutrophil effector responses induced by CVB3 infection. Effector 
responses were determined in non-infected (control and mock) and infected neutrophils. 
A) Myeloperoxidase (MPO) activity was measured in supernatants after 3 h of infection. B) 













cells with dihydrorhodamine. C) NET formation was evaluated by incubating neutrophils for 
3 h with CVB3 at MOI of 1 and with or without TNF-α (10 ng/ml). The cells were then fixed, 
permeabilized, stained with PI for DNA (red) and the specific marker anti-human neutrophil 
elastase (HNE, green) and visualized by confocal fluorescence microscopy. Original 
magnification, 60x (scale bar: 20 μm). D) Neutrophils were incubated with CVB3, TNF-α or 
TNF-α (10 ng/ml) plus CVB3 (MOI=1) in the absence or presence of bafilomycin A1 (50 
nM), after which the DNA was quantified in the supernatants by fluorometry. TL8 506 was 
used as a TLR-8 agonist. The results are the mean±SEM of four to five independent 
experiments (*P < 0.05, and ***P < 0.001 vs. control, #P < 0.05 and ##P < 0.01).  
Figure 7. CVB3 internalization by neutrophils in infected mouse  A) Representative 
flow cytometry dot plots of Ly6G+ neutrophils (G1) in peripheral white blood cells (WBC) 
from non-infected and infected mice at 2 dpi. B) Representative histogram graphs of VP1 
of G1 from non-infected and infected mice and Vero cells (positive control of VP1 staining). 
C) CVB3 mRNA (RNA) was detected by RT-PCR in WBC from non-infected (1) and: total 
(2), sorted Ly6G+neutrophils (3) or sorted Ly6G- mononuclear cells (4) from WBC infected 
mice. A representative of three independent experiments is shown. 
Figure 8. Neutrophil depletion mildly decreases viremia and heart viral titers. 
Neutrophil depletion was induced by intra-peritoneal inoculation with 100 µl of PBS 
containing 100 µg of anti-Ly6G (1A8) every 24 h. Control mice were inoculated with an 
isotype Ab (clone 2A3) under the same conditions. The first inoculation was performed one 
day before infection and then every 24 h. The mice were infected intraperitoneally with 
2x105 PFU of virus in 200 µl of PBS (CVB3) and 100 µg of isotype (Iso+CVB3) or 1A8 
(1A8+CVB3). A) Hematological counts were performed using a veterinary hematological 
analyzer. B) Blood was collected by retro-orbital venous puncture and viremia was 
determined in plasma samples at 2 dpi. C) At day 7 pi, the infectivity titers were 













mean±SEM of five independent experiments (*** P < 0.001 vs. control, ## P < 0.01). 
ND=not detected. 
Figure 9. Neutrophil depletion decreases the severity of CVB3-induced myocarditis 
by reducing cardiomyocyte area, gene expression of CCL-2 and total inflammatory 
cell infiltration in the heart. A) Representative images of hematoxylin/eosin-stained 
sections from murine hearts collected at 7 dpi (original magnification 100x and 400x and 
squares indicate myocarditic lesions) and assessed by blinded histopathological scoring of 
myocarditis lesions was performed by optical microscopic examination of cardiac sections. 
B) mRNA expression levels of CCL-2 were measured by qPCR at 7 dpi in murine hearts. 
C) Representative images of immunohistochemical studies using cell-specific antibodies 
from cardiac muscle samples at 7 dpi. 1A8 (neutrophils); Mac-2 (macrophages); CD45R (B 
lymphocytes); CD4 and CD8 (T lymphocytes). Scale bar represents 25   μm. D) 
Representative pictures of WGA‐stained myocardial cross sections and quantitative 
analysis of cardiomyocyte cross-sectional area. Scale bar represents 25  μm. The results 
are the mean±SEM of five independent experiments. (**P < 0.01 and ****P < 0.0001 vs 















Table I. Cardiac cell infiltrate composition. 
*P<0.05, n=3 
  
 Total cells Neutrophils 
(% of total 
cells) 
Macrophages 
(% of total 
cells) 
T Lymphocytes 
(% of total cells) 
B 
Lymphocytes 

































-Coxsackievirus B3 (CVB3) interacts with, but does not replicate in human neutrophils. 
-CVB3 increases neutrophil survival, CD11b expression, cytokine and IL-8 release. 
-CVB3 triggers neutrophil release of myeloperoxidase and NETs. 
-Neutrophils sense CVB3 mainly through TLR-8 and the activation of NFκB. 
-Neutrophil-depleted CVB3-infected mice exhibit reduced viral myocarditis. 
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